Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
39.09
+1.59 (4.24%)
Jun 4, 2026, 12:28 PM EDT - Market open
Structure Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $100 | Buy | Maintains | $100 | +155.82% | May 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $104 | Buy | Reiterates | $104 | +166.05% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $101 | Buy | Reiterates | $101 | +158.38% | May 8, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $140 | Buy | Maintains | $140 | +258.15% | May 8, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $101 | Buy | Maintains | $101 | +158.38% | May 8, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 7, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $102 → $101 | Buy | Maintains | $102 → $101 | +158.38% | Mar 17, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $130 → $145 | Buy | Reiterates | $130 → $145 | +270.94% | Mar 17, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.